Hüppa sisu juurde

Onkoloogia

Pretreatment Planning and Patient Optimization

Preoperative anaemia is associated with poor clinical outcome in non-cardiac surgery patients. (opens new window)

Baron DM, Hochrieser H, Posch M, Metnitz B, Rhodes A, Moreno RP, Pearse RM, Metnitz P; European Surgical Outcomes Study (EuSOS) group for Trials Groups of European Society of Intensive Care Medicine; European Society of Anaesthesiology.

Allikas‎: Br J Anaesth 2014;113(3):416-23.

Indekseeritud‎: PubMed 24829444

DOI‎: 10.1093/bja/aeu098

https://www.ncbi.nlm.nih.gov/pubmed/24829444 (opens new window)

Intraoperative bleeding and haemostasis during pelvic surgery for locally advanced or recurrent rectal cancer: a prospective evaluation. (opens new window)

Bonello VA, Bhangu A, Fitzgerald JE, Rasheed S, Tekkis P.

Allikas‎: Tech Coloproctol 2014;18(10):887-93.

Indekseeritud‎: PubMed 24890577

DOI‎: 10.1007/s10151-014-1150-z

https://www.ncbi.nlm.nih.gov/pubmed/24890577 (opens new window)

A cohort investigation of anaemia, treatment and the use of allogeneic blood transfusion in colorectal cancer surgery. (opens new window)

Keeler BD, Mishra A, Stavrou CL, Beeby S, Simpson JA, Acheson AG.

Allikas‎: Ann Med Surg (Lond) 2016;6:6-11.

Indekseeritud‎: PubMed 26909150

DOI‎: 10.1016/j.amsu.2015.12.052

https://www.ncbi.nlm.nih.gov/pubmed/26909150 (opens new window)

The theory and practice of bloodless surgery. (opens new window)

Martyn V, Farmer SL, Wren MN, Towler SC, Betta J, Shander A, Spence RK, Leahy MF.

Allikas‎: Transfus Apher Sci 2002;27(1):29-43.

Indekseeritud‎: PubMed 12201468

https://www.ncbi.nlm.nih.gov/pubmed/12201468 (opens new window)

Non-blood medical care in gynecologic oncology: a review and update of blood conservation management schemes. (opens new window)

Simou M, Thomakos N, Zagouri F, Vlysmas A, Akrivos N, Zacharakis D, Papadimitriou CA, Dimopoulos MA, Rodolakis A, Antsaklis A.

Allikas‎: World J Surg Oncol 2011;9:142.

Indekseeritud‎: PubMed 22051161

DOI‎: 10.1186/1477-7819-9-142

https://www.ncbi.nlm.nih.gov/pubmed/22051161 (opens new window)

Effects of trilaciclib on chemotherapy-induced myelosuppression and patient-reported outcomes in patients with extensive-stage small cell lung cancer: Pooled results from three phase ii randomized, double-blind, placebo-controlled studies. (opens new window)

Weiss J, Goldschmidt J, Andric Z, Dragnev KH, Gwaltney C, Skaltsa K, Pritchett Y, Antal JM, Morris SR, Daniel D

Allikas‎: Clin Lung Cancer 2021;22(5):449-60. 

Indekseeritud‎: PubMed 33895103

DOI‎: 10.1016/j.cllc.2021.03.010

https://pubmed.ncbi.nlm.nih.gov/33895103/ (opens new window)

Adverse effects on hemostatic function of drugs used in hematologic malignancies. (opens new window)

Zakarija A, Kwaan HC.

Allikas‎: Semin Thromb Hemost 2007;33(4):355-64.

Indekseeritud‎: PubMed 17525893

DOI‎: 10.1055/s-2007-976171

https://www.ncbi.nlm.nih.gov/pubmed/17525893 (opens new window)